Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Healthcare REIT (AHR) Receivables (2016 - 2025)

Historic Receivables for American Healthcare REIT (AHR) over the last 10 years, with Q3 2025 value amounting to $357.6 million.

  • American Healthcare REIT's Receivables fell 387.49% to $357.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $357.6 million, marking a year-over-year decrease of 387.49%. This contributed to the annual value of $378.1 million for FY2024, which is 1331.28% up from last year.
  • As of Q3 2025, American Healthcare REIT's Receivables stood at $357.6 million, which was down 387.49% from $401.6 million recorded in Q2 2025.
  • American Healthcare REIT's 5-year Receivables high stood at $401.6 million for Q2 2025, and its period low was $2.8 million during Q2 2021.
  • For the 5-year period, American Healthcare REIT's Receivables averaged around $266.0 million, with its median value being $268.0 million (2023).
  • As far as peak fluctuations go, American Healthcare REIT's Receivables crashed by 5790.66% in 2021, and later surged by 838658.58% in 2022.
  • Quarter analysis of 5 years shows American Healthcare REIT's Receivables stood at $217.7 million in 2021, then rose by 19.19% to $259.5 million in 2022, then grew by 28.58% to $333.7 million in 2023, then rose by 13.31% to $378.1 million in 2024, then fell by 5.42% to $357.6 million in 2025.
  • Its Receivables was $357.6 million in Q3 2025, compared to $401.6 million in Q2 2025 and $400.2 million in Q1 2025.